Results 221 to 230 of about 1,207,844 (359)

A Transient Developmental Hematopoietic Stem Cell Gives Rise to Innate-like B and T Cells.

open access: yesCell Stem Cell, 2016
Anna E. Beaudin   +8 more
semanticscholar   +1 more source

Safety and Effectiveness of Sutimlimab in Cold Agglutinin Disease: A Real‐World International Experience

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Sutimlimab is a monoclonal antibody against complement fraction C1s approved for the treatment of hemolytic anemia due to cold agglutinin disease (CAD). Here, we analyzed and report the largest international CAD cohort of sutimlimab‐treated patients ever reported to highlight its safety and effectiveness in the real‐world setting. We accrued a
Bruno Fattizzo   +38 more
wiley   +1 more source

Transient mechanical activation of the Piezo1 channel facilitates ex vivo expansion of hematopoietic stem cells. [PDF]

open access: yesCell Res
Wang Q   +22 more
europepmc   +1 more source

AC133, a novel marker for human hematopoietic stem and progenitor cells.

open access: yesBlood, 1997
A. Yin   +8 more
semanticscholar   +1 more source

Circulating Tumor Cells in Multiple Myeloma: From Peripheral Clues to Central Insights

open access: yesAmerican Journal of Hematology, EarlyView.
CTC offer a minimally invasive widow into systemic myeloma biology, overcoming the sampling bias of bone marrow biopsies. Their prognostic value at diagnosis, potential role in MRD monitoring, and ability to capture clonal evolution highlight them as actionable biomarkers for future precision medicine.
Benjamin Podvin   +3 more
wiley   +1 more source

Functional correction and genome integrity with duplex base editing of β-thalassemic hematopoietic stem cells. [PDF]

open access: yesGenome Biol
Papaioannou NY   +11 more
europepmc   +1 more source

Late Cytomegalovirus Infections After Allogeneic Hematopoietic Cell Transplant

open access: yesAmerican Journal of Hematology, EarlyView.
ABSTRACT Graft versus host disease (GVHD) prophylaxis with posttransplant cyclophosphamide (ptCY) and cytomegalovirus (CMV) prophylaxis with letermovir have changed the clinical epidemiology of CMV infection. We studied the incidence, risk factors for, and outcomes of CMV infection after Day + 90 of allogeneic hematopoietic cell transplant (alloHCT ...
George L. Chen   +15 more
wiley   +1 more source

The hematopoietic stem cells supportive megakaryocytes as shapers of the bone marrow niche. [PDF]

open access: yesEur J Histochem
Arciprete F   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy